Bellvitge Biomedical Research Institute
Barcelona
Description:
A Postdoctoral Contract is offered in the Chromatin and Disease Group (led by Dr. Esteban Ballestar) within the Cancer Epigenetics and Biology Programme (PEBC) at the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona. Research in the laboratory focuses in epigenetic deregulation mechanisms in the immune system, particularly in the context of autoimmune disease and different differentiation models relevant to immune-related disease [Javierre et al. (2010) Genome Res. 20, 170-179; Ballestar (2011) Nature Reviews Rheumatology 7, 263-271; Rodriguez-Ubreva et al. (2012) Nucleic Acids Research 40, 1954-1968]. The Chromatin and Disease Group (PEBC, IDIBELL) has recently been awarded with a FP7 EU grant for the integration of next-generation sequencing (NGS) data using an immune system model. The project joins efforts from eleven international and multidisciplinary labs and
companies to create the bioinformatics and biostatistical framework for the integrative analysis of NGS, proteomics and metabolomics data. We are seeking for an enthusiastic researcher with strong background in both generation and bioinformatic analysis of high-throughput epigenomics/miRNA expression data.
companies to create the bioinformatics and biostatistical framework for the integrative analysis of NGS, proteomics and metabolomics data. We are seeking for an enthusiastic researcher with strong background in both generation and bioinformatic analysis of high-throughput epigenomics/miRNA expression data.
Requirements:
- PhD degree in Biology, Molecular Biology, Genetics or related.
- PhD degree in Biology, Molecular Biology, Genetics or related.
- Strong background in bioinformatic analysis of high-throughput DNA methylation, ChIP-on-chip and/or ChIP-seq data.
- Advanced English Level.
- Advanced English Level.
Conditions:
- Full time contract for a 3 year period.
- Starting date: October 1, 2012
- Applications must include curriculum vitae with a cover letter and contacts for 2 references.
- Full time contract for a 3 year period.
- Starting date: October 1, 2012
- Applications must include curriculum vitae with a cover letter and contacts for 2 references.
Additional information:
Dr. Esteban Ballestar
Chromatin and Disease Group
Cancer Epigenetics and Biology Programme (PEBC)
Bellvitge Biomedical Research Institute (IDIBELL)
Avda. Gran Via 199-203
08908 L´Hospitalet de Llobregat, Barcelona, Spain
Dr. Esteban Ballestar
Chromatin and Disease Group
Cancer Epigenetics and Biology Programme (PEBC)
Bellvitge Biomedical Research Institute (IDIBELL)
Avda. Gran Via 199-203
08908 L´Hospitalet de Llobregat, Barcelona, Spain
No comments:
Post a Comment